Galiz Research, LLC

Miami Springs, Florida 33166

0 studies enrolling now · 4 studies all time

What they study most

Alzheimer's Disease, Crohn Disease, Crohn's Disease

Studies at this site

• A Six Week Efficacy, Safety and Tolerability Study of V565 in Crohn's Disease — Completed
• Multiple Dose Study of Aducanumab (BIIB037) (Recombinant, Fully Human Anti-Aβ IgG1 mAb) in Participants With Prodromal or Mild Alzheimer's Disease — Stopped early
• Efficacy and Safety Study of Mongersen (GED-0301) for the Treatment of Subjects With Active Crohn's Disease — Stopped early
• A Study of Efficacy and Safety of Mongersen (GED-0301) for the Treatment of Adult and Adolescent Subjects With Active Crohn's Disease — Withdrawn before enrolling